Epigenetic Signatures Predict Pathologic Nodal Stage in Breast Cancer Patients with Estrogen Receptor-Positive, Clinically Node-Positive Disease

Abstract

Department

Description

Provenance

Subjects

Citation

Published Version (Please cite this version)

10.1245/s10434-022-11684-0

Publication Info

Ensenyat-Mendez, Miquel, Dennis Rünger, Javier IJ Orozco, Julie Le, Jennifer L Baker, Joanne Weidhaas, Diego M Marzese, Maggie L DiNome, et al. (n.d.). Epigenetic Signatures Predict Pathologic Nodal Stage in Breast Cancer Patients with Estrogen Receptor-Positive, Clinically Node-Positive Disease. Annals of Surgical Oncology. 10.1245/s10434-022-11684-0 Retrieved from https://hdl.handle.net/10161/24794.

This is constructed from limited available data and may be imprecise. To cite this article, please review & use the official citation provided by the journal.

Scholars@Duke

DiNome

Maggie L DiNome

Professor of Surgery

I am a faculty member at Duke in the Department of Surgery, Division of Surgical Oncology. I am a surgical breast oncologist whose clinical research interests focus on the de-escalation of axillary surgery for patients with lymph node positive breast cancer. My translational research interests focus on epigenetic modifications in breast cancer. I have returned to Duke (Medical School 1994), having spent the past 20 years in Los Angeles, most recently at UCLA where I served as Chief of Breast Surgery and Director of Breast Health for the UCLA Health System. I am honored to have joined the Duke faculty and am eager to grow the program in Wake County as the medical director of breast cancer services.


Unless otherwise indicated, scholarly articles published by Duke faculty members are made available here with a CC-BY-NC (Creative Commons Attribution Non-Commercial) license, as enabled by the Duke Open Access Policy. If you wish to use the materials in ways not already permitted under CC-BY-NC, please consult the copyright owner. Other materials are made available here through the author’s grant of a non-exclusive license to make their work openly accessible.